Crinetics Pharmaceuticals, Inc.·4

Feb 26, 4:18 PM ET

Krasner Alan Seth 4

4 · Crinetics Pharmaceuticals, Inc. · Filed Feb 26, 2020

Insider Transaction Report

Form 4
Period: 2020-02-24
Krasner Alan Seth
Chief Medical Officer
Transactions
  • Award

    Stock Option (right to buy)

    2020-02-24+45,00045,000 total
    Exercise: $22.61Exp: 2030-02-23Common Stock (45,000 underlying)
Footnotes (1)
  • [F1]The stock option shall vest and become exercisable in a series of forty-eight (48) successive equal monthly installments measured from the vesting commencement date of February 24, 2020.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION